Literature DB >> 28329230

3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study.

Anne Bernard1,2, Karima Addetia3, Raluca Dulgheru1, Luis Caballero4, Tadafumi Sugimoto1, Natela Akhaladze5, George D Athanassopoulos6, Daniele Barone7, Monica Baroni8, Nuno Cardim9, Andreas Hagendorff10, Krasimira Hristova11, Federica Ilardi1, Teresa Lopez12, Gonzalo de la Morena4, Bogdan A Popescu13, Martin Penicka14, Tolga Ozyigit15, Jose David Rodrigo Carbonero16, Nico van de Veire17, Ralph Stephan Von Bardeleben18, Dragos Vinereanu19, Jose Luis Zamorano20, Christophe Martinez1, Julien Magne21, Bernard Cosyns22, Erwan Donal23, Gilbert Habib24,25, Luigi P Badano26, Roberto M Lang3, Patrizio Lancellotti1,27.   

Abstract

AIM: To obtain the normal ranges for 3D echocardiography (3DE) measurement of left ventricular (LV) volumes, function, and strain from a large group of healthy volunteers. METHODS AND
RESULTS: A total of 440 (mean age: 45 ± 13 years) out of the 734 healthy subjects enrolled at 22 collaborating institutions of the Normal Reference Ranges for Echocardiography (NORRE) study had good-quality 3DE data sets that have been analysed with a vendor-independent software package allowing homogeneous measurements regardless of the echocardiographic machine used to acquire the data sets. Upper limits of LV end-diastolic and end-systolic volumes were larger in men (97 and 42 mL/m2) than in women (82 and 35 mL/m2; P < 0.0001). Conversely, lower limits of LV ejection fraction were higher in women than in men (51% vs. 50%; P < 0.01). Similarly, all strain components were higher in women than in men. Lower range was -18.6% in men and -19.5% in women for 3D longitudinal strain, -27.0% and -27.6% for 3D circumferential strain, -33.2% and -34.4% for 3D tangential strain and 38.8% and 40.7% for 3D radial strain, respectively. LV volumes decreased with age in both genders (P < 0.0001), whereas LV ejection fraction increased with age only in men. Among 3DE LV strain components, the only one, which did not change with age was longitudinal strain.
CONCLUSION: The NORRE study provides applicable 3D echocardiographic reference ranges for LV function assessment. Our data highlight the importance of age- and gender-specific reference values for both LV volumes and strain. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  adult echocardiography ; deformation imaging ; left ventricular function ; reference values; three-dimensional echocardiography

Mesh:

Year:  2017        PMID: 28329230     DOI: 10.1093/ehjci/jew284

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  23 in total

Review 1.  Adult echocardiographic nomograms: overview, critical review and creation of a software for automatic, fast and easy calculation of normal values.

Authors:  Massimiliano Cantinotti; Raffaele Giordano; Marco Paterni; Daniel Saura; Marco Scalese; Eliana Franchi; Nadia Assanta; Martin Koestenberg; Raluca Dulgheru; Tadafumi Sugimoto; Anne Bernard; Luis Caballero; Patrizio Lancellotti
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

Review 2.  Expert proposal to characterize cardiac diseases with normal or preserved left ventricular ejection fraction and symptoms of heart failure by comprehensive echocardiography.

Authors:  A Hagendorff; A Helfen; R Brandt; E Altiok; O Breithardt; D Haghi; J Knierim; D Lavall; N Merke; C Sinning; S Stöbe; C Tschöpe; F Knebel; S Ewen
Journal:  Clin Res Cardiol       Date:  2022-06-04       Impact factor: 5.460

Review 3.  Standardization of normal values for cardiac chamber size in echocardiography.

Authors:  Tatsuya Miyoshi; Hidekazu Tanaka
Journal:  J Med Ultrason (2001)       Date:  2021-11-17       Impact factor: 1.314

4.  Medium-Term Cardiac Outcomes in Young People with Multi-system Inflammatory Syndrome: The Era of COVID-19.

Authors:  James Wong; Paraskevi Theocharis; William Regan; Kuberan Pushparajah; Natasha Stephenson; Emma Pascall; Aoife Cleary; Laura O'Byrne; Alex Savis; Owen Miller
Journal:  Pediatr Cardiol       Date:  2022-04-29       Impact factor: 1.838

Review 5.  Innovation in 3D Echocardiographic Imaging.

Authors:  Pei-Ni Jone; Nee Khoo
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-01-19

6.  Determining the thresholds for abnormal left ventricular strains in healthy subjects by echocardiography: a meta-analysis.

Authors:  Tom Kai Ming Wang; Milind Y Desai; Patrick Collier; Richard A Grimm; Brian P Griffin; Zoran B Popović
Journal:  Cardiovasc Diagn Ther       Date:  2020-12

Review 7.  Aging and myocardial strain.

Authors:  Koki Nakanishi; Masao Daimon
Journal:  J Med Ultrason (2001)       Date:  2021-07-23       Impact factor: 1.314

Review 8.  Quality Assurance and Improvement Project in Echocardiography Laboratory: The Pivotal Importance of Organizational and Managerial Processes.

Authors:  Antoine Kossaify
Journal:  Heart Views       Date:  2021-04-22

9.  Comparative Analysis of Right Ventricle Fluid Dynamics.

Authors:  Dario Collia; Luigino Zovatto; Giovanni Tonti; Gianni Pedrizzetti
Journal:  Front Bioeng Biotechnol       Date:  2021-07-06

10.  Normal Values of Cardiac Output and Stroke Volume According to Measurement Technique, Age, Sex, and Ethnicity: Results of the World Alliance of Societies of Echocardiography Study.

Authors:  Hena N Patel; Tatsuya Miyoshi; Karima Addetia; Michael P Henry; Rodolfo Citro; Masao Daimon; Pedro Gutierrez Fajardo; Ravi R Kasliwal; James N Kirkpatrick; Mark J Monaghan; Denisa Muraru; Kofo O Ogunyankin; Seung Woo Park; Ricardo E Ronderos; Anita Sadeghpour; Gregory M Scalia; Masaaki Takeuchi; Wendy Tsang; Edwin S Tucay; Ana Clara Tude Rodrigues; Amuthan Vivekanandan; Yun Zhang; Marcus Schreckenberg; Michael Blankenhagen; Markus Degel; Alexander Rossmanith; Victor Mor-Avi; Federico M Asch; Roberto M Lang
Journal:  J Am Soc Echocardiogr       Date:  2021-05-25       Impact factor: 7.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.